Why allergy and immunology work stays with a person
The job turns on judgment while a patient is in the room. An oral food challenge, a first build-up dose of immunotherapy, a drug desensitization: each one can tip into anaphylaxis within minutes. Someone licensed has to watch the patient, decide when to stop, and push epinephrine. Software can flag a risk score. It cannot own the decision or the consequence.
Testing is physical too. Skin prick and intradermal placement, reading a wheal and flare against the patient’s antihistamine use, repeating a borderline result: that is hands and eyes at a bedside. So is examining a child with eczema and wheeze whose parents disagree about what triggered it.
Then there is the long arc. Allergy and immune conditions are chronic. Plans change across pollen seasons, school years, pregnancies and new biologics. The share of task time our model leaves with a person is 56%, and most of that is this kind of continuing, accountable care.
What AI handles, what it assists, what it leaves alone
Routine paperwork is where software already carries real weight. Ambient scribes draft the visit note from the conversation. Templates generate after-visit instructions, school epinephrine letters and prior-authorization text. Our estimate of the task time AI can take on its own is 0%.
Assistive use is broader. Models can line up a specific IgE panel against a food history and suggest which results look like sensitization rather than true allergy. They can summarize a thick referral chart, surface the latest trial evidence on a biologic, and pre-sort a triage queue. The share where AI works alongside the physician is 44%, which is why total task coverage sits at 24 on our 0 to 100 scale. The way that figure is built is set out in how coverage is scored.
What stays untouched is the physical and the consequential: performing and reading the tests, running challenges and immunotherapy, and sitting with a family to decide whether a child reintroduces peanut at home. Those tasks need a licensed clinician present, not a recommendation on a screen.
What has actually been tested, and what has not
Our evidence grade for this job is D. That means there is no direct head-to-head test of AI against board-certified allergists in this occupation yet, so we publish no parity number for it. Plenty has been written about AI in allergy care. Very little has been measured against practicing specialists on their own caseload.
A study that would settle it is not exotic. Take consecutive real referrals. Have a model and a panel of allergists each produce a working diagnosis, a test plan and a management plan. Score agreement, missed diagnoses, unnecessary testing, and, most of all, safety calls around challenges and immunotherapy dosing. Follow the patients. Until something like that exists, judgments about parity are opinion. Our rule for scoring the question is explained in is it better than a person.
The market context is steadier. Federal data puts employment in this physician group at 342,720 with median pay of $265,930, and projects 3.4% growth between 2025 and 2035 (BLS, 2025). Demand is not falling.
When the picture could shift
Most likely between 2041 and 2057 (8 in 10 of our scenarios). What that window measures is described on our replacement-year method page.
Two things could pull it earlier. First, health systems are now buying AI built for care delivery rather than adapted from consumer tools, so decision support may arrive inside the record instead of beside it. Second, cost: running a model against a chart is cheap next to a physician hour, and the page’s cost comparison shows how wide that gap is.
Two things hold it back. Liability and licensure sit with a named clinician, and no regulator has moved that line. And the hands-on slice of this job would need dexterous humanoid hardware to perform skin testing, place intradermal injections and manage a reaction. That hardware is not deployed in allergy clinics, and the robotics section above shows how much of the work depends on it.
How allergists stay needed
Lean into the tasks that sit furthest from a model. Run the testing and the challenges yourself, and keep ownership of immunotherapy build-up and reaction management. Hold the complex immunodeficiency and mast cell cases, where the history matters more than the panel. Do the counseling that changes behavior: what a family actually does at a birthday party, not what the chart says.
Two skills raise your value either way. One is reading model output critically, including knowing when a sensitization result is being over-read. The other is communication under uncertainty, which is what turns an ambiguous panel into a plan a patient will follow.
What to do: ask for the audit trail on any decision-support tool your group adopts, and check who is accountable when it is wrong.
Nearby physician roles face a similar split between documentation and bedside judgment. Compare this page with Pediatricians, General, General Internal Medicine Physicians and Dermatologists, or put any two of them beside each other with our job comparison tool. The wider picture sits on the diagnosing and treating practitioners family page and the healthcare sector page, and you can see which occupations hold up best on our list of the jobs least exposed. Every score here is built from open data using the published scoring method.